The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Incyte; Merck; MSD; Servier/Pfizer
Research Funding - BeiGene (Inst)
Adjuvant capecitabine in resected biliary tract cancers: Real life data from a multicenter study (PRODIGE83-ACABi-PRONOBIL).
 
Anthony Turpin
No Relationships to Disclose
 
Claire Noe
No Relationships to Disclose
 
Brice Chanez
Employment - AstraZeneca; Bristol-Myers Squibb; SERVIER
Leadership - SERVIER
Honoraria - Amgen (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb; SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Pfizer; SERVIER; SERVIER
 
Dewi Vernerey
Consulting or Advisory Role - AC BioScience; Apmonia Therapeutics; cellprothera; CURE51; Fondazione Smith Kline; GERCOR; HalioDx; INCYTE; INVECTYS; Janssen-Cilag; OSE Immunotherapeutics; Pfizer; Veracyte
Travel, Accommodations, Expenses - MSD
 
Thierry Lecomte
No Relationships to Disclose
 
Thomas Walter
No Relationships to Disclose
 
Eric Assenat
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Sanofi; SERVIER
Research Funding - Roche
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Basilea; Bayer; BeiGene; Boston Scientific; Bristol-Myers Squibb; BTG; Eisai; Incyte; Ipsen; Merck Serono; MSD; Roche; SERVIER; Taiho Oncology
Research Funding - Beigene (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Exeliom Biosciences
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Alexandra Heurgue
Speakers' Bureau - AstraZeneca; Bayer; Ipsen; Roche; SERVIER
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; BMS; MSD; Novartis; Pierre Fabre; Sanofi; SERVIER; Takeda
Research Funding - BTG (Inst); Gilead Sciences (Inst); MSD (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Pierre Fabre; Roche; SERVIER
 
Sylvain Manfredi
No Relationships to Disclose
 
Vincent Hautefeuille
Honoraria - Advanced Accelerator Applications; Amgen; Deciphera; Esteve; Ipsen; Merck KGaA; Novartis; Sanofi; SERVIER
Research Funding - Ipsen
Travel, Accommodations, Expenses - Amgen; Ipsen; Novartis; Pfizer; Sanofi
 
Cindy Neuzillet
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Baxter; Bristol-Myers Squibb; Fresenius Kabi; Healthcare nutrition; Incyte; Merck; MSD; Mundipharma; Nestle Health Science; Novartis; Nutricia; OSE Immunotherapeutics; Pierre Fabre; Roche; Sanofi; SERVIER; Viatris
Research Funding - AstraZeneca; Bristol-Myers Squibb; Fresenius; Nutricia; OSE Immunotherapeutics; Roche; SERVIER; Viatris
 
Gael Roth
Consulting or Advisory Role - Alpha Tau; Amgen; AstraZeneca; Bristol-Myers Squibb; Incyte; Ipsen; MSD; Netris Pharma; Pierre Fabre; SERVIER
Research Funding - GenoScience Pharma; Netris Pharma
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Ipsen; MSD; Pierre Fabre; Roche; Servier/Pfizer; Viatris
 
Jean-Paul Lagasse
No Relationships to Disclose
 
Christophe Tournigand
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst)
(OPTIONAL) Uncompensated Relationships - Fondation APHP (Inst)
 
Aude Guillemin
No Relationships to Disclose
 
Antoine Hollebecque
Honoraria - Amgen; Eisai; Incyte; Relay Therapeutics; SERVIER
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune (Inst); Debiopharm Group (Inst); Gritstone Bio; Incyte (Inst); Lilly (Inst); QED therapeutics; Relay Therapeutics; Sanofi; Spectrum Pharmaceuticals (Inst); Taiho Oncology; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Incyte; Lilly; Roche; SERVIER
Other Relationship - Abbvie; Agios; Amgen; argenx; Arno Therapeutics; Astex Pharmaceuticals; AstraZeneca; AVEO; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Clovis Oncology; Daiichi Sankyo; Debiopharm Group; Eisai; Exelixis; FORMA Therapeutics; GamaMabs Pharma; Genentech; GlaxoSmithKline; H3 Biomedicine; Innate Pharma; Janssen-Cilag; Kyowa Hakko Kirin; Lilly; Loxo; Lytix Biopharma; MedImmune; Menarini; Merck Sharp & Dohme; Merrimack; Merus; Millenium Pharamceuticals; Nanobiotix; Nektar; Novartis; Octimet; Oncoethix; Onyx; Orion; Oryzon Genomics; Pfizer; Pierre Fabre; Roche; Roche/Genentech; Sanofi/Aventis; SERVIER; Taiho Pharmaceutical; Tesaro; Xencor
 
Julie Henriques
No Relationships to Disclose
 
Pauline Parent
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb